Prostate cancer screening
Intervention3 papers3 findings
Outcomes
3Adverse events
no changein humans1RR 1.32High certainty
1 study
Adverse events
no changein humans1RR 1.32High certainty
Prostate cancer screening has no effect on adverse events in humans (RR 1.32, 95% CI 0.48-3.65).
Reviewin men with no prior diagnosis of prostate cancer
The PSA test for prostate cancer screening: an abridged Cochrane review · BJU international · 1 Oct 2026
Prostate cancer-specific mortality
downin humans1RR 0.87High certainty
1 study
Prostate cancer-specific mortality
downin humans1RR 0.87High certainty
Prostate cancer screening decreases prostate cancer-specific mortality in humans (RR 0.87, 95% CI 0.80-0.95).
Reviewin men with no prior diagnosis of prostate cancern = 162,236
The PSA test for prostate cancer screening: an abridged Cochrane review · BJU international · 1 Oct 2026
Mortality
downin humans1
1 study
Mortality
downin humans1
Prostate cancer screening decreases mortality in humans (very small).
Review
Prostate cancer screening: Evidence uncertainty and implications for patient education and counseling · Patient education and counseling · 26 Sep 2026